FAH Statement on Costs Related to the No Surprises Act IDR Process

Washington, D.C. (August 28, 2025) – FAH President and CEO Chip Kahn released the following statement on costs related to the No Surprises Act IDR process as published in Health Affairs. “Insurers are costing Americans […]

Read More… from FAH Statement on Costs Related to the No Surprises Act IDR Process

FAH Recommends Deregulation Agenda to HHS

Today, FAH submitted comprehensive comments to the US Department of Health and Human Services (HHS) in response to its Request for Information (RFI): Ensuring Lawful Regulation and Unleashing Innovation To Make America Healthy Again, which seeks […]

Read More… from FAH Recommends Deregulation Agenda to HHS